Literature DB >> 23631740

Rapid measurement of intracellular unbound drug concentrations.

André Mateus1, Pär Matsson, Per Artursson.   

Abstract

Intracellular unbound drug concentrations determine affinity to targets in the cell interior. However, due to difficulties in measuring them, they are often overlooked in pharmacology. Here we present a simple experimental technique for the determination of unbound intracellular drug concentrations in cultured cells that is based on parallel measurements of cellular drug binding and steady-state intracellular drug concentrations. Binding in HEK293 cells was highly correlated with binding in liver-derived systems, whereas binding in plasma did not compare well with cellular binding. Compound lipophilicity increased drug binding, while negative charge and aromatic functional groups decreased binding. Intracellular accumulation of unbound drug was consistent with pH-dependent subcellular sequestration, as confirmed by modeling and by inhibition of subcellular pH gradients. The approach developed here can be used to measure intracellular unbound drug concentrations in more complex systems, for example, cell lines with controlled expression of transporters and enzymes or primary cells.

Mesh:

Substances:

Year:  2013        PMID: 23631740     DOI: 10.1021/mp4000822

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  44 in total

1.  Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.

Authors:  Nathan D Pfeifer; Kevin B Harris; Grace Zhixia Yan; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-08-29       Impact factor: 3.922

2.  Controlling cellular distribution of drugs with permeability modifying moieties.

Authors:  Paul L Richardson; Violeta L Marin; Stormy L Koeniger; Aleksandra Baranczak; Julie L Wilsbacher; Peter J Kovar; Patricia E Bacon-Trusk; Min Cheng; Todd A Hopkins; Sandra T Haman; Anil Vasudevan
Journal:  Medchemcomm       Date:  2019-04-18       Impact factor: 3.597

3.  Structural and conformational determinants of macrocycle cell permeability.

Authors:  Björn Over; Pär Matsson; Christian Tyrchan; Per Artursson; Bradley C Doak; Michael A Foley; Constanze Hilgendorf; Stephen E Johnston; Maurice D Lee; Richard J Lewis; Patrick McCarren; Giovanni Muncipinto; Ulf Norinder; Matthew W D Perry; Jeremy R Duvall; Jan Kihlberg
Journal:  Nat Chem Biol       Date:  2016-10-17       Impact factor: 15.040

4.  Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies.

Authors:  Nikolaos Tsamandouras; Wen Li Kelly Chen; Collin D Edington; Cynthia L Stokes; Linda G Griffith; Murat Cirit
Journal:  AAPS J       Date:  2017-07-27       Impact factor: 4.009

5.  Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.

Authors:  Melina M Malinen; Izna Ali; Jacqueline Bezençon; James J Beaudoin; Kim L R Brouwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-08       Impact factor: 4.052

6.  Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.

Authors:  André Mateus; Laurie J Gordon; Gareth J Wayne; Helena Almqvist; Hanna Axelsson; Brinton Seashore-Ludlow; Andrea Treyer; Pär Matsson; Thomas Lundbäck; Andy West; Michael M Hann; Per Artursson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

7.  Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation.

Authors:  Cen Guo; Kyunghee Yang; Kenneth R Brouwer; Robert L St Claire; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2016-05-27       Impact factor: 4.030

8.  Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.

Authors:  Yingying Guo; Xiaoyan Chu; Neil J Parrott; Kim L R Brouwer; Vicky Hsu; Swati Nagar; Pär Matsson; Pradeep Sharma; Jan Snoeys; Yuichi Sugiyama; Daniel Tatosian; Jashvant D Unadkat; Shiew-Mei Huang; Aleksandra Galetin
Journal:  Clin Pharmacol Ther       Date:  2018-09-12       Impact factor: 6.875

Review 9.  Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

Authors:  X Chu; K Korzekwa; R Elsby; K Fenner; A Galetin; Y Lai; P Matsson; A Moss; S Nagar; G R Rosania; J P F Bai; J W Polli; Y Sugiyama; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

10.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.